The unusually high frequency of occurrence of diabetes mellitus with Friedreich's ataxia and the presumption that many recessive disorders will be found to be associated with detectable enzyme deficiencies has led to Friedreich's ataxia being considered as an inherited metabolic disease.' However, despite extensive investigations by numerous workers, this cerebellar ataxia has resisted precise biochemical definition.2 3 In 1974 Kark et a14 reported that muscle from a third of patients with an in'herited ataxia of the Friedreich type oxidized pyruvic acid more slowly than normal controls. Subsequently, a possible deficiency of the pyruvate and the 2-oxoglutarate dehydrogenase complexes affecting the common third enzyme of the complexes has been postulated by Blass et al.5 6 Alternatively a kinetic abnormality of the enzyme lipoamide dehydrogenase could account for the observations.7 8 These results have not been confirmed by others7 and it is still unclear whether defects in pyruvate oxidation or lipoamide dehydrogenase occur in patients with "classical" Friedreich's ataxia. Abnormalities of amino acid metabolism especially of taurine and aspartic acid, alterations in high density lipoprotein composition of serum9 and hyperbilirubinaemial' have all been suggested but these, when they occur, are secondary effects and the primary defect has not yet been found. Mitochondrial energy deprivation due to altered phospholipids in the inner mitochondrial mem'brane has recently been suggested as a basic cause of the disorder.'1 The present study was designed to reinvestigate some aspects of metabolism in Friedreichs' ataxia in a controlled in-patient environment with careful selection of only those patients diagnosed on clinical, genetical and physiological grounds as having Friedreich's ataxia.
Patients and methods
Twenty patients were chosen for the study using the following criteria as evidence for the diagnosis of Friedreich's ataxia. All except one of the patients had an onset before the age of 20 Biochemical tests A full routine biochemical screening was carried out on the blood of each patient. Urea, sodium, potassium, total protein, albumin, total globulins, calcium, phosphate, bilirubin, creatinine and uric acid were determined using standard clinical chemistry automated techniques. In some of the patients, iron and iron binding capacity was determined. Thyroxine and T3 uptake were determined by radioimmunoassay, cholesterol was determined enzymically using cholesterol oxidase and lipoproteins were determined using nephelometry. The following enzymes were determined in the patients' blood: lactate dehydrogenase and aspartate aminotransferase using the Scandinavian recommended methods,14 alkaline phosphatase using an automated version of the method of Kind and King. ' Thirteen of the patients had an oral alanine loading test to elucidate any abnormalities in pyruvate metabolism or gluconeogenesis. 500 mg L-a-alanine/kg body weight were administered, in water, and blood samples were obtained as described for the glucose loading test. A group of six normal volunteers from the laboratory, age 21-37 years also had alanine and glucose loading tests under the same conditions as the patients. Whole blood pyruvate and lactate concentrations were determined using lactate dehydrogenase and a standard test kit (Boehringer (London)) and insulins were measured by radioimmunoassay at the Supraregional Assay Laboratory, Guildford, Results from the glucose and alanine loading tests are shown in figs 1 and 2. A wide spread, illustrated by the standard error of the mean, was obtained when the results for each patient were plotted individually and one patient showed a typical diabetic response to the glucose load. This patient was omitted from the analysis presented here. Throughout the loading tests, the "zero" time sample was drawn immediately before the glucose or alanine was administered and so represents a true baseline value.
Analysis of figure 1 shows that the mean glucose levels in patients with Friedreich's ataxia were higher than those of controls at all times except prior to loading. There was evidence of an enhanced lactate response at times between 60 and 120 minutes post loading but the differences were not statistically significant. There was no difference in pyruvate response between the two groups. The insulin concentrations for the patients, however, were higher than control values throughout the test. The return to pre-load values was delayed in the patients by comparison with the controls.
No differences between controls and patients were observed as a result of oral L-a-alanine loading ( fig 2) and urinary organic acids remained normal throughout both glucose and alanine loading tests. 
